These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16285993)

  • 1. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study.
    Hoogeveen RC; Morrison A; Boerwinkle E; Miles JS; Rhodes CE; Sharrett AR; Ballantyne CM
    Atherosclerosis; 2005 Dec; 183(2):301-7. PubMed ID: 16285993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
    Petrkova J; Szotkowska J; Hermanova Z; Lukl J; Petrek M
    Mediators Inflamm; 2004 Feb; 13(1):39-43. PubMed ID: 15203564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
    Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.
    Wattanakit K; Folsom AR; Selvin E; Weatherley BD; Pankow JS; Brancati FL; Hirsch AT
    Atherosclerosis; 2005 Jun; 180(2):389-97. PubMed ID: 15910867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study.
    Wattanakit K; Folsom AR; Selvin E; Coresh J; Hirsch AT; Weatherley BD
    J Am Soc Nephrol; 2007 Feb; 18(2):629-36. PubMed ID: 17215445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
    Deo R; Khera A; McGuire DK; Murphy SA; Meo Neto Jde P; Morrow DA; de Lemos JA
    J Am Coll Cardiol; 2004 Nov; 44(9):1812-8. PubMed ID: 15519012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Appiah D; Schreiner PJ; MacLehose RF; Folsom AR
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2700-6. PubMed ID: 26494231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between plasma monocyte chemoattractant protein-1 levels and the extent of atherosclerotic peripheral artery disease.
    Satiroglu O; Uydu HA; Demir A; Bostan M; Atak M; Bozkurt E
    Tohoku J Exp Med; 2011 Aug; 224(4):301-6. PubMed ID: 21799302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of vascular inflammation are associated with the extent of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial occlusive disease.
    Nylaende M; Kroese A; Stranden E; Morken B; Sandbaek G; Lindahl AK; Arnesen H; Seljeflot I
    Vasc Med; 2006 Feb; 11(1):21-8. PubMed ID: 16669409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
    Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
    J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of peripheral arterial occlusive disease with major coronary events in a mediterranean population with low coronary heart disease incidence.
    Merino J; Planas A; De Moner A; Gasol A; Contreras C; Marrugat J; Vidal-Barraquer F; Clarà A
    Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):71-6. PubMed ID: 18396072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort.
    Reich LM; Heiss G; Boland LL; Hirsch AT; Wu K; Folsom AR
    Vasc Med; 2007 Nov; 12(4):267-73. PubMed ID: 18048462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EN-RAGE: a novel inflammatory marker for incident coronary heart disease.
    Ligthart S; Sedaghat S; Ikram MA; Hofman A; Franco OH; Dehghan A
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2695-9. PubMed ID: 25341801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: the Atherosclerosis Risk in Communities Study.
    Volcik KA; Ballantyne CM; Coresh J; Folsom AR; Wu KK; Boerwinkle E
    Atherosclerosis; 2006 May; 186(1):74-9. PubMed ID: 16125711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
    Herder C; Baumert J; Thorand B; Martin S; Löwel H; Kolb H; Koenig W
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2147-52. PubMed ID: 16825597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating CD40 ligand is elevated only in patients with more advanced symptomatic peripheral arterial diseases.
    Lee WJ; Sheu WH; Chen YT; Liu TJ; Liang KW; Ting CT; Lee WL
    Thromb Res; 2006; 118(5):619-26. PubMed ID: 16356539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
    Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma cytokines as predictors of coronary heart disease.
    Okopień B; Haberka M; Cwalina L; Kowalski J; Belowski D; Madej A; Zieliński M; Krysiak R; Labuzek K; Kalina Z; Herman ZS
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):5-15. PubMed ID: 15080492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies.
    Georgakis MK; de Lemos JA; Ayers C; Wang B; Björkbacka H; Pana TA; Thorand B; Sun C; Fani L; Malik R; Dupuis J; Engström G; Orho-Melander M; Melander O; Boekholdt SM; Zierer A; Elhadad MA; Koenig W; Herder C; Hoogeveen RC; Kavousi M; Ballantyne CM; Peters A; Myint PK; Nilsson J; Benjamin EJ; Dichgans M
    JAMA Cardiol; 2021 May; 6(5):587-592. PubMed ID: 33146689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Underrecognized peripheral arterial disease in patients with acute coronary syndrome: prevalence of traditional and emergent cardiovascular risk factors].
    Huelmos A; Jiménez J; Guijarro C; Belinchón JC; Puras E; Sánchez C; Casas ML; López-Bescos L
    Rev Esp Cardiol; 2005 Dec; 58(12):1403-10. PubMed ID: 16371199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.